0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Duchenne Muscular Dystrophy Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-19M314
Home | Category |Health |Health Conditions |Genetic Disorders
Global Duchenne Muscular Dystrophy Market Insights Forecast to 2025

Global Duchenne Muscular Dystrophy Market Insights, Forecast to 2025

Code: QYRE-Auto-19M314
Report
May 2019
115 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The classification of duchenne muscular dystrophy includes deflazacort, prednisone and others. And the proportion of deflazacort in 2017 is about 44%.
Duchenne muscular dystrophy is widely used by Male patients and Female patients. The most proportion of duchenne muscular dystrophy sold to Male patients, and the proportion in 2017 is about 81%.
The global Duchenne Muscular Dystrophy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Duchenne Muscular Dystrophy market based on company, product type, end user and key regions.

This report studies the global market size of Duchenne Muscular Dystrophy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Duchenne Muscular Dystrophy in these regions.
This research report categorizes the global Duchenne Muscular Dystrophy market by top players/brands, region, type and end user. This report also studies the global Duchenne Muscular Dystrophy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    PTC Therapeutics
    Sarepta Therapeutics
    Others

Market size by Product
    Deflazacort
    Prednisone
    Others
Market size by End User
    Male
    Female

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Duchenne Muscular Dystrophy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Duchenne Muscular Dystrophy market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Duchenne Muscular Dystrophy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Duchenne Muscular Dystrophy submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Duchenne Muscular Dystrophy are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Duchenne Muscular Dystrophy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Duchenne Muscular Dystrophy Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Duchenne Muscular Dystrophy Market Size Growth Rate by Product
        1.4.2 Deflazacort
        1.4.3 Prednisone
        1.4.4 Others
    1.5 Market by End User
        1.5.1 Global Duchenne Muscular Dystrophy Market Size Growth Rate by End User
        1.5.2 Male
        1.5.3 Female
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Duchenne Muscular Dystrophy Market Size
        2.1.1 Global Duchenne Muscular Dystrophy Revenue 2014-2025
        2.1.2 Global Duchenne Muscular Dystrophy Sales 2014-2025
    2.2 Duchenne Muscular Dystrophy Growth Rate by Regions
        2.2.1 Global Duchenne Muscular Dystrophy Sales by Regions
        2.2.2 Global Duchenne Muscular Dystrophy Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Duchenne Muscular Dystrophy Sales by Manufacturers
        3.1.1 Duchenne Muscular Dystrophy Sales by Manufacturers
        3.1.2 Duchenne Muscular Dystrophy Sales Market Share by Manufacturers
        3.1.3 Global Duchenne Muscular Dystrophy Market Concentration Ratio (CR5 and HHI)
    3.2 Duchenne Muscular Dystrophy Revenue by Manufacturers
        3.2.1 Duchenne Muscular Dystrophy Revenue by Manufacturers (2014-2019)
        3.2.2 Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2014-2019)
    3.3 Duchenne Muscular Dystrophy Price by Manufacturers
    3.4 Duchenne Muscular Dystrophy Manufacturing Base Distribution, Product Types
        3.4.1 Duchenne Muscular Dystrophy Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Duchenne Muscular Dystrophy Product Type
        3.4.3 Date of International Manufacturers Enter into Duchenne Muscular Dystrophy Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Duchenne Muscular Dystrophy Sales by Product
    4.2 Global Duchenne Muscular Dystrophy Revenue by Product
    4.3 Duchenne Muscular Dystrophy Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Duchenne Muscular Dystrophy Breakdown Data by End User

6 North America
    6.1 North America Duchenne Muscular Dystrophy by Countries
        6.1.1 North America Duchenne Muscular Dystrophy Sales by Countries
        6.1.2 North America Duchenne Muscular Dystrophy Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Duchenne Muscular Dystrophy by Product
    6.3 North America Duchenne Muscular Dystrophy by End User

7 Europe
    7.1 Europe Duchenne Muscular Dystrophy by Countries
        7.1.1 Europe Duchenne Muscular Dystrophy Sales by Countries
        7.1.2 Europe Duchenne Muscular Dystrophy Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Duchenne Muscular Dystrophy by Product
    7.3 Europe Duchenne Muscular Dystrophy by End User

8 Asia Pacific
    8.1 Asia Pacific Duchenne Muscular Dystrophy by Countries
        8.1.1 Asia Pacific Duchenne Muscular Dystrophy Sales by Countries
        8.1.2 Asia Pacific Duchenne Muscular Dystrophy Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Duchenne Muscular Dystrophy by Product
    8.3 Asia Pacific Duchenne Muscular Dystrophy by End User

9 Central & South America
    9.1 Central & South America Duchenne Muscular Dystrophy by Countries
        9.1.1 Central & South America Duchenne Muscular Dystrophy Sales by Countries
        9.1.2 Central & South America Duchenne Muscular Dystrophy Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Duchenne Muscular Dystrophy by Product
    9.3 Central & South America Duchenne Muscular Dystrophy by End User

10 Middle East and Africa
    10.1 Middle East and Africa Duchenne Muscular Dystrophy by Countries
        10.1.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Countries
        10.1.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Duchenne Muscular Dystrophy by Product
    10.3 Middle East and Africa Duchenne Muscular Dystrophy by End User

11 Company Profiles
    11.1 PTC Therapeutics
        11.1.1 PTC Therapeutics Company Details
        11.1.2 Company Business Overview
        11.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 PTC Therapeutics Duchenne Muscular Dystrophy Products Offered
        11.1.5 PTC Therapeutics Recent Development
    11.2 Sarepta Therapeutics
        11.2.1 Sarepta Therapeutics Company Details
        11.2.2 Company Business Overview
        11.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Products Offered
        11.2.5 Sarepta Therapeutics Recent Development
    11.3 Others
        11.3.1 Others Company Details
        11.3.2 Company Business Overview
        11.3.3 Others Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Others Duchenne Muscular Dystrophy Products Offered
        11.3.5 Others Recent Development

12 Future Forecast
    12.1 Duchenne Muscular Dystrophy Market Forecast by Regions
        12.1.1 Global Duchenne Muscular Dystrophy Sales Forecast by Regions 2019-2025
        12.1.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Regions 2019-2025
    12.2 Duchenne Muscular Dystrophy Market Forecast by Product
        12.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Product 2019-2025
        12.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Product 2019-2025
    12.3 Duchenne Muscular Dystrophy Market Forecast by End User
    12.4 North America Duchenne Muscular Dystrophy Forecast
    12.5 Europe Duchenne Muscular Dystrophy Forecast
    12.6 Asia Pacific Duchenne Muscular Dystrophy Forecast
    12.7 Central & South America Duchenne Muscular Dystrophy Forecast
    12.8 Middle East and Africa Duchenne Muscular Dystrophy Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Duchenne Muscular Dystrophy Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Duchenne Muscular Dystrophy Product Picture
    Table Duchenne Muscular Dystrophy Market Segments
    Table Key Manufacturers Duchenne Muscular Dystrophy Covered
    Table Global Duchenne Muscular Dystrophy Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product 2014-2025
    Figure Deflazacort Product Picture
    Table Major Manufacturers of Deflazacort
    Figure Prednisone Product Picture
    Table Major Manufacturers of Prednisone
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Duchenne Muscular Dystrophy Market Size Growth Rate by End User 2019-2025 (K Doses)
    Figure Male
    Figure Female
    Figure Duchenne Muscular Dystrophy Report Years Considered
    Figure Global Duchenne Muscular Dystrophy Market Size 2014-2025 (Million US$)
    Figure Global Duchenne Muscular Dystrophy Sales 2014-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Market Size by Regions 2014-2019 (K Doses) & (Million US$)
    Table Global Duchenne Muscular Dystrophy Sales by Regions 2014-2019 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share by Regions 2014-2019
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Regions 2014-2019
    Figure 2018 Global Duchenne Muscular Dystrophy Sales Market Share by Regions
    Table Global Duchenne Muscular Dystrophy Revenue by Regions 2014-2019 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share by Regions 2014-2019
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Duchenne Muscular Dystrophy Revenue Market Share by Regions
    Table Global Duchenne Muscular Dystrophy Sales by Manufacturers (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by Manufacturers (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Duchenne Muscular Dystrophy Revenue by Manufacturers (2014-2019) (Million USD)
    Table Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2014-2019)
    Figure Duchenne Muscular Dystrophy Value Share by Manufacturers in 2018
    Table Key Manufacturers Duchenne Muscular Dystrophy Price (2014-2019) (USD/Dose)
    Table Duchenne Muscular Dystrophy Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Duchenne Muscular Dystrophy Product Type
    Table Date of International Manufacturers Enter into Duchenne Muscular Dystrophy Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product in 2018
    Table Global Duchenne Muscular Dystrophy Revenue by Product (2014-2019) (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Product in 2018
    Table Duchenne Muscular Dystrophy Price by Product 2014-2019 (USD/Dose)
    Table Global Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by End User (2014-2019)
    Figure Global Sales Duchenne Muscular Dystrophy Market Share by End User (2014-2019)
    Figure Global Sales Duchenne Muscular Dystrophy Market Share by End User in 2018
    Figure North America Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table North America Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure United States Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure United States Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (K Doses)
    Figure Canada Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Canada Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Mexico Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Market Share by Product
    Table North America Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Market Share by End User
    Figure Europe Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Europe Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure Germany Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Germany Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure France Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure UK Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Italy Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Russia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Market Share by Product
    Table Europe Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Market Share by End User
    Figure Asia Pacific Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Asia Pacific Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Asia Pacific Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure China Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure China Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Korea Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure India Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Australia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Indonesia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Malaysia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Philippines Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Thailand Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Vietnam Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Singapore Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Market Share by Product
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Market Share by End User
    Figure Central & South America Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Central & South America Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Central & South America Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure Brazil Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Brazil Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Argentina Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Market Share by Product
    Table Central & South America Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Market Share by End User
    Figure Middle East and Africa Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure GCC Countries Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure GCC Countries Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Turkey Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Egypt Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure South Africa Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Market Share by Product
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Market Share by End User
    Table PTC Therapeutics Company Details
    Table PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table PTC Therapeutics Recent Development
    Table Sarepta Therapeutics Company Details
    Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table Sarepta Therapeutics Recent Development
    Table Others Company Details
    Table Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table Others Recent Development
    Table Global Duchenne Muscular Dystrophy Sales Forecast by Regions 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Regions 2019-2025
    Table Global Duchenne Muscular Dystrophy Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Regions 2019-2025
    Table Global Duchenne Muscular Dystrophy Sales Forecast by Product 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Product 2019-2025
    Table Global Duchenne Muscular Dystrophy Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Product 2019-2025
    Table Global Duchenne Muscular Dystrophy Sales Forecast by End User 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by End User 2019-2025
    Figure North America Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Asia Pacific Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Central & South America Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Duchenne Muscular Dystrophy Value Chain
    Table Duchenne Muscular Dystrophy Customers List
    Table Duchenne Muscular Dystrophy Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The classification of duchenne muscular dystrophy includes deflazacort, prednisone and others. And the proportion of deflazacort in 2017 is about 44%.
Duchenne muscular dystrophy is widely used by Male patients and Female patients. The most proportion of duchenne muscular dystrophy sold to Male patients, and the proportion in 2017 is about 81%.
The global Duchenne Muscular Dystrophy market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Duchenne Muscular Dystrophy market based on company, product type, end user and key regions.

This report studies the global market size of Duchenne Muscular Dystrophy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Duchenne Muscular Dystrophy in these regions.
This research report categorizes the global Duchenne Muscular Dystrophy market by top players/brands, region, type and end user. This report also studies the global Duchenne Muscular Dystrophy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    PTC Therapeutics
    Sarepta Therapeutics
    Others

Market size by Product
    Deflazacort
    Prednisone
    Others
Market size by End User
    Male
    Female

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Duchenne Muscular Dystrophy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Duchenne Muscular Dystrophy market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Duchenne Muscular Dystrophy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Duchenne Muscular Dystrophy submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Duchenne Muscular Dystrophy are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Duchenne Muscular Dystrophy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Study Coverage
    1.1 Duchenne Muscular Dystrophy Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Duchenne Muscular Dystrophy Market Size Growth Rate by Product
        1.4.2 Deflazacort
        1.4.3 Prednisone
        1.4.4 Others
    1.5 Market by End User
        1.5.1 Global Duchenne Muscular Dystrophy Market Size Growth Rate by End User
        1.5.2 Male
        1.5.3 Female
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Duchenne Muscular Dystrophy Market Size
        2.1.1 Global Duchenne Muscular Dystrophy Revenue 2014-2025
        2.1.2 Global Duchenne Muscular Dystrophy Sales 2014-2025
    2.2 Duchenne Muscular Dystrophy Growth Rate by Regions
        2.2.1 Global Duchenne Muscular Dystrophy Sales by Regions
        2.2.2 Global Duchenne Muscular Dystrophy Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Duchenne Muscular Dystrophy Sales by Manufacturers
        3.1.1 Duchenne Muscular Dystrophy Sales by Manufacturers
        3.1.2 Duchenne Muscular Dystrophy Sales Market Share by Manufacturers
        3.1.3 Global Duchenne Muscular Dystrophy Market Concentration Ratio (CR5 and HHI)
    3.2 Duchenne Muscular Dystrophy Revenue by Manufacturers
        3.2.1 Duchenne Muscular Dystrophy Revenue by Manufacturers (2014-2019)
        3.2.2 Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2014-2019)
    3.3 Duchenne Muscular Dystrophy Price by Manufacturers
    3.4 Duchenne Muscular Dystrophy Manufacturing Base Distribution, Product Types
        3.4.1 Duchenne Muscular Dystrophy Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Duchenne Muscular Dystrophy Product Type
        3.4.3 Date of International Manufacturers Enter into Duchenne Muscular Dystrophy Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Duchenne Muscular Dystrophy Sales by Product
    4.2 Global Duchenne Muscular Dystrophy Revenue by Product
    4.3 Duchenne Muscular Dystrophy Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Duchenne Muscular Dystrophy Breakdown Data by End User

6 North America
    6.1 North America Duchenne Muscular Dystrophy by Countries
        6.1.1 North America Duchenne Muscular Dystrophy Sales by Countries
        6.1.2 North America Duchenne Muscular Dystrophy Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Duchenne Muscular Dystrophy by Product
    6.3 North America Duchenne Muscular Dystrophy by End User

7 Europe
    7.1 Europe Duchenne Muscular Dystrophy by Countries
        7.1.1 Europe Duchenne Muscular Dystrophy Sales by Countries
        7.1.2 Europe Duchenne Muscular Dystrophy Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Duchenne Muscular Dystrophy by Product
    7.3 Europe Duchenne Muscular Dystrophy by End User

8 Asia Pacific
    8.1 Asia Pacific Duchenne Muscular Dystrophy by Countries
        8.1.1 Asia Pacific Duchenne Muscular Dystrophy Sales by Countries
        8.1.2 Asia Pacific Duchenne Muscular Dystrophy Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Duchenne Muscular Dystrophy by Product
    8.3 Asia Pacific Duchenne Muscular Dystrophy by End User

9 Central & South America
    9.1 Central & South America Duchenne Muscular Dystrophy by Countries
        9.1.1 Central & South America Duchenne Muscular Dystrophy Sales by Countries
        9.1.2 Central & South America Duchenne Muscular Dystrophy Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Duchenne Muscular Dystrophy by Product
    9.3 Central & South America Duchenne Muscular Dystrophy by End User

10 Middle East and Africa
    10.1 Middle East and Africa Duchenne Muscular Dystrophy by Countries
        10.1.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Countries
        10.1.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Duchenne Muscular Dystrophy by Product
    10.3 Middle East and Africa Duchenne Muscular Dystrophy by End User

11 Company Profiles
    11.1 PTC Therapeutics
        11.1.1 PTC Therapeutics Company Details
        11.1.2 Company Business Overview
        11.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 PTC Therapeutics Duchenne Muscular Dystrophy Products Offered
        11.1.5 PTC Therapeutics Recent Development
    11.2 Sarepta Therapeutics
        11.2.1 Sarepta Therapeutics Company Details
        11.2.2 Company Business Overview
        11.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Products Offered
        11.2.5 Sarepta Therapeutics Recent Development
    11.3 Others
        11.3.1 Others Company Details
        11.3.2 Company Business Overview
        11.3.3 Others Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Others Duchenne Muscular Dystrophy Products Offered
        11.3.5 Others Recent Development

12 Future Forecast
    12.1 Duchenne Muscular Dystrophy Market Forecast by Regions
        12.1.1 Global Duchenne Muscular Dystrophy Sales Forecast by Regions 2019-2025
        12.1.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Regions 2019-2025
    12.2 Duchenne Muscular Dystrophy Market Forecast by Product
        12.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Product 2019-2025
        12.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Product 2019-2025
    12.3 Duchenne Muscular Dystrophy Market Forecast by End User
    12.4 North America Duchenne Muscular Dystrophy Forecast
    12.5 Europe Duchenne Muscular Dystrophy Forecast
    12.6 Asia Pacific Duchenne Muscular Dystrophy Forecast
    12.7 Central & South America Duchenne Muscular Dystrophy Forecast
    12.8 Middle East and Africa Duchenne Muscular Dystrophy Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Duchenne Muscular Dystrophy Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures

    Figure Duchenne Muscular Dystrophy Product Picture
    Table Duchenne Muscular Dystrophy Market Segments
    Table Key Manufacturers Duchenne Muscular Dystrophy Covered
    Table Global Duchenne Muscular Dystrophy Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product 2014-2025
    Figure Deflazacort Product Picture
    Table Major Manufacturers of Deflazacort
    Figure Prednisone Product Picture
    Table Major Manufacturers of Prednisone
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Duchenne Muscular Dystrophy Market Size Growth Rate by End User 2019-2025 (K Doses)
    Figure Male
    Figure Female
    Figure Duchenne Muscular Dystrophy Report Years Considered
    Figure Global Duchenne Muscular Dystrophy Market Size 2014-2025 (Million US$)
    Figure Global Duchenne Muscular Dystrophy Sales 2014-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Market Size by Regions 2014-2019 (K Doses) & (Million US$)
    Table Global Duchenne Muscular Dystrophy Sales by Regions 2014-2019 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share by Regions 2014-2019
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Regions 2014-2019
    Figure 2018 Global Duchenne Muscular Dystrophy Sales Market Share by Regions
    Table Global Duchenne Muscular Dystrophy Revenue by Regions 2014-2019 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share by Regions 2014-2019
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Duchenne Muscular Dystrophy Revenue Market Share by Regions
    Table Global Duchenne Muscular Dystrophy Sales by Manufacturers (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by Manufacturers (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Duchenne Muscular Dystrophy Revenue by Manufacturers (2014-2019) (Million USD)
    Table Duchenne Muscular Dystrophy Revenue Share by Manufacturers (2014-2019)
    Figure Duchenne Muscular Dystrophy Value Share by Manufacturers in 2018
    Table Key Manufacturers Duchenne Muscular Dystrophy Price (2014-2019) (USD/Dose)
    Table Duchenne Muscular Dystrophy Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Duchenne Muscular Dystrophy Product Type
    Table Date of International Manufacturers Enter into Duchenne Muscular Dystrophy Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Sales Market Share by Product in 2018
    Table Global Duchenne Muscular Dystrophy Revenue by Product (2014-2019) (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Product (2014-2019)
    Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Product in 2018
    Table Duchenne Muscular Dystrophy Price by Product 2014-2019 (USD/Dose)
    Table Global Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Share by End User (2014-2019)
    Figure Global Sales Duchenne Muscular Dystrophy Market Share by End User (2014-2019)
    Figure Global Sales Duchenne Muscular Dystrophy Market Share by End User in 2018
    Figure North America Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table North America Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure United States Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure United States Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (K Doses)
    Figure Canada Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Canada Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Mexico Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Market Share by Product
    Table North America Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table North America Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 North America Duchenne Muscular Dystrophy Market Share by End User
    Figure Europe Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Europe Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure Germany Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Germany Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure France Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure UK Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Italy Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Russia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Market Share by Product
    Table Europe Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Europe Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Duchenne Muscular Dystrophy Market Share by End User
    Figure Asia Pacific Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Asia Pacific Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Asia Pacific Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure China Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure China Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Korea Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure India Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Australia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Indonesia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Malaysia Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Philippines Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Thailand Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Vietnam Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Singapore Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Market Share by Product
    Table Asia Pacific Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Asia Pacific Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Duchenne Muscular Dystrophy Market Share by End User
    Figure Central & South America Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Central & South America Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Central & South America Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure Brazil Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Brazil Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Argentina Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Market Share by Product
    Table Central & South America Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Central & South America Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Duchenne Muscular Dystrophy Market Share by End User
    Figure Middle East and Africa Duchenne Muscular Dystrophy Sales Growth Rate 2014-2019 (K Doses)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by Countries (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Countries
    Table Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Revenue Market Share by Countries
    Figure GCC Countries Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure GCC Countries Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Turkey Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure Egypt Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Duchenne Muscular Dystrophy Sales Growth Rate (2014-2019) (K Doses)
    Figure South Africa Duchenne Muscular Dystrophy Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by Product (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Market Share by Product
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales by End User (2014-2019) (K Doses)
    Table Middle East and Africa Duchenne Muscular Dystrophy Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Duchenne Muscular Dystrophy Market Share by End User
    Table PTC Therapeutics Company Details
    Table PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table PTC Therapeutics Recent Development
    Table Sarepta Therapeutics Company Details
    Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table Sarepta Therapeutics Recent Development
    Table Others Company Details
    Table Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
    Table Others Recent Development
    Table Global Duchenne Muscular Dystrophy Sales Forecast by Regions 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Regions 2019-2025
    Table Global Duchenne Muscular Dystrophy Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Regions 2019-2025
    Table Global Duchenne Muscular Dystrophy Sales Forecast by Product 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Product 2019-2025
    Table Global Duchenne Muscular Dystrophy Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Product 2019-2025
    Table Global Duchenne Muscular Dystrophy Sales Forecast by End User 2019-2025 (K Doses)
    Table Global Duchenne Muscular Dystrophy Sales Market Share Forecast by End User 2019-2025
    Figure North America Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Asia Pacific Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Central & South America Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Sales Growth Rate Forecast (2019-2025) (K Doses)
    Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Duchenne Muscular Dystrophy Value Chain
    Table Duchenne Muscular Dystrophy Customers List
    Table Duchenne Muscular Dystrophy Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
0 Items
X
No items in the cart.
$0.0